Celgene Corp (NASDAQ: CELG)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 07/19/2019
Closing price: 90.20
|Support price level:||N/A|
|Resistance price level:||$93.25|
|Relative strength index (14-day RSI)||34.5|
- CELG is one of this month's worst performers with a return of -8.1%, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- CELG is above its 200-day moving average, providing a measure of support for long positions.
- Price broke below prior support level - a short-term bearish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 7.0% in the next week.
- 16.6% in the next month.
- 68.2% in the next year.